Quentis Therapeutics

OverviewSuggest Edit

Quentis Therapeutics develops immunotherapies targeting the endoplasmic reticulum stress response to awaken the immune system’s ability to fight cancer. The Company is at the forefront of the next generation of immuno-oncology companies that are translating novel biology into therapeutic approaches.

TypePrivate
Founded2016
HQNew York, NY, US
Websitequentistx.com

Latest Updates

Employees (est.) (Apr 2020)6(-40%)
Cybersecurity ratingBMore

Key People/Management at Quentis Therapeutics

Michael Aberman

Michael Aberman

President, CEO and Director
Juan Cubillos-Ruiz

Juan Cubillos-Ruiz

Advisor and Scientific Founder
Jeanne Magram

Jeanne Magram

Chief Scientific Officer
Show more

Quentis Therapeutics Office Locations

Quentis Therapeutics has an office in New York
New York, NY, US (HQ)
430 E 29th St #1005
Show all (1)

Quentis Therapeutics Financials and Metrics

Summary Metrics

Founding Date

2016

Quentis Therapeutics total Funding

$48 m

Quentis Therapeutics latest funding size

$48 m

Time since last funding

4 years ago

Quentis Therapeutics investors

Quentis Therapeutics's latest funding round in February 2018 was reported to be $48 m. In total, Quentis Therapeutics has raised $48 m
Show all financial metrics

Quentis Therapeutics Cybersecurity Score

Cybersecurity ratingPremium dataset

B

87/100

SecurityScorecard logo

Quentis Therapeutics Online and Social Media Presence

Embed Graph

Quentis Therapeutics Blogs

NYC-Based Quentis Therapeutics is Named a “Fierce 15” Biotech Company of 2018

New York, NY – Oct. 2, 2018 – Quentis Therapeutics, Inc., a biotechnology company developing therapies that target endoplasmic reticulum (ER) stress pathways, today announced … The post NYC-Based Quentis Therapeutics is Named a “Fierce 15” Biotech Company of 2018 appeared first on Quentis Therapeuti…

Quentis Therapeutics Frequently Asked Questions

  • When was Quentis Therapeutics founded?

    Quentis Therapeutics was founded in 2016.

  • Who are Quentis Therapeutics key executives?

    Quentis Therapeutics's key executives are Michael Aberman, Juan Cubillos-Ruiz and Jeanne Magram.

  • How many employees does Quentis Therapeutics have?

    Quentis Therapeutics has 6 employees.

  • Who are Quentis Therapeutics competitors?

    Competitors of Quentis Therapeutics include MABION, TCR CURE Biopharma and Dualogics.

  • Where is Quentis Therapeutics headquarters?

    Quentis Therapeutics headquarters is located at 430 E 29th St #1005, New York.

  • Where are Quentis Therapeutics offices?

    Quentis Therapeutics has an office in New York.

  • How many offices does Quentis Therapeutics have?

    Quentis Therapeutics has 1 office.